Recent analysts Ratings for Chico’s FAS, Inc.(NYSE:CHS): ENDRA Life Sciences Inc.(NASDAQ:NDRA)

0
1

Chico’s FAS, Inc. (CHS) will report its next earnings on Nov 26 BMO. The company reported the earnings of $-0.04/Share in the last quarter where the estimated EPS by analysts was $-0.06/share. The difference between the expected and actual EPS was $0.02/share, which represents an Earnings surprise of 33.3%.

Many analysts are providing their Estimated Earnings analysis for Chico’s FAS, Inc. and for the current quarter 7 analysts have projected that the stock could give an Average Earnings estimate of $-0.14/share. These analysts have also projected a Low Estimate of $-0.21/share and a High Estimate of $-0.11/share.

In case of Revenue Estimates, 6 analysts have provided their consensus Average Revenue Estimates for Chico’s FAS, Inc. as 509.95 Million. According to these analysts, the Low Revenue Estimate for Chico’s FAS, Inc. is 503.3 Million and the High Revenue Estimate is 519.6 Million. The company had Year Ago Sales of 524.73 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for CHS to be -85.7%. They are projecting Next Quarter growth of 160%. For the next 5 years, Chico’s FAS, Inc. is expecting Growth of 34.67% per annum, whereas in the past 5 years the growth was -148.39% per annum.

Some buy side analysts are also providing their Analysis on Chico’s FAS, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

Chico’s FAS, Inc. closed its last trading session at $5.06 with the loss of -5.73%. The Market Capitalization of the company stands at 562.19 Million. The Company has 52-week high of $6.46 and 52-week low of $2.33. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 22.26% where SMA50 and SMA200 are 28.68% and 25.71% respectively. The Company Touched its 52-Week High on 01/09/19 and 52-Week Low on 08/28/19.

The Relative Volume of the company is 0.75 and Average Volume (3 months) is 2.79 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -0.7%. The Return on Equity (ROE) value stands at -1.7%. While it’s Return on Investment (ROI) value is 4.9%.

While looking at the Stock’s Performance, Chico’s FAS, Inc. currently shows a Weekly Performance of 30.68%, where Monthly Performance is 32.5%, Quarterly performance is 52.88%, 6 Months performance is 36.29% and yearly performance percentage is -0.42%. Year to Date performance value (YTD perf) value is -15.12%. The Stock currently has a Weekly Volatility of 10.21% and Monthly Volatility of 6.32%.

ENDRA Life Sciences Inc. (NDRA) will report its next earnings on Nov 13 AMC. The company reported the earnings of $-0.46/Share in the last quarter where the estimated EPS by analysts was $-0.3/share. The difference between the expected and actual EPS was $-0.16/share, which represents an Earnings surprise of -53.3%.

Many analysts are providing their Estimated Earnings analysis for ENDRA Life Sciences Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $-0.29/share. These analysts have also projected a Low Estimate of $-0.38/share and a High Estimate of $-0.13/share.

Some buy side analysts are also providing their Analysis on ENDRA Life Sciences Inc., where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

ENDRA Life Sciences Inc. closed its last trading session at $0.77 with the gain of 9.13%. The Market Capitalization of the company stands at 6.05 Million. The Company has 52-week high of $4.05 and 52-week low of $0.62. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -9.33% where SMA50 and SMA200 are -22.91% and -44.06% respectively. The Company Touched its 52-Week High on 03/21/19 and 52-Week Low on 11/21/19.

The Relative Volume of the company is 0.47 and Average Volume (3 months) is 82.08 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -232.8%. The Return on Equity (ROE) value stands at -327.3%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, ENDRA Life Sciences Inc. currently shows a Weekly Performance of 23.38%, where Monthly Performance is -21.18%, Quarterly performance is -50.64%, 6 Months performance is -25.74% and yearly performance percentage is -75.17%. Year to Date performance value (YTD perf) value is -44.06%. The Stock currently has a Weekly Volatility of 6.86% and Monthly Volatility of 8.64%.

SHARE